Virtual Presentation

2009 HCV Advanced Practice Curriculum: Fibrosis and Disease Progression in HCV

Source: Hepatitis C Advanced Practice Curriculum 2009

2009 HCV Advanced Practice Curriculum: Fibrosis and Disease Progression in HCV

Program Director: Gary L. Davis, MD

Faculty:

Raymond T. Chung, MD

CREDIT INFORMATION

Release Date: June 12, 2009

Expiration Date: June 11, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Recall the current and projected burden of hepatitis C–related complications in the United States
Discuss methods to assess the severity of liver disease
Recount factors that contribute to the progression of advanced liver disease
Explain how hepatitis C treatment impacts the natural history of the disease

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.